Search results
Results from the WOW.Com Content Network
The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus. Shares of the company were up 2.2% in extended trading after ...
The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 ...
The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine amid the summer surge of infections. The new version of the ...
Novavax’s vaccine is included in the recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC) on June 27, 2024. ... the FDA granted Emergency Use Authorization to ...
The Food and Drug Administration on Tuesday authorized an updated version of Novavax's Covid vaccine, allowing doses to begin shipping to doctors' offices and pharmacies across the country.
The US Food and Drug Administration on Tuesday authorized Novavax’s updated protein-based Covid-19 vaccine for people 12 and older. The US Food and Drug Administration on Tuesday authorized ...
The Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even as Moderna and Novavax — makers of two of the three COVID vaccines — submitted their ...
The FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets the older JN.1 variant, the FDA said fall 2024 vaccines should target a newer strain of the virus.